The cases received highlighted the fact that aberrant phenotypic features such as CD10 and BCL6 expression may occur in P/B-MCL and raised issues in the diagnosis of cyclin D1-negative P/B-MCL. This evidence concerns the gene BCL6 and mantle cell lymphoma.